Sachs; David H.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Sachs; David H..The latest application filed is for "anti-human chemokine (c-c motif) receptor 4 immunotoxins".
- Sachs; David H. - Newton MA
- Sachs; David H. - Charlestown MA
- Sachs; David H. - Auburndale MA
| Patent | Date |
|---|---|
| Miniature swine transgenic for one or more coagulation factors Grant 9,980,471 - Sachs , et al. May 29, 2 | 2018-05-29 |
| Human CTLA4 mutants and use thereof Grant 9,944,689 - Wang , et al. April 17, 2 | 2018-04-17 |
| Reducing immunogenicity of xenogeneic transplant tissues Grant 9,883,939 - Yamada , et al. February 6, 2 | 2018-02-06 |
| Bivalent IL-2 fusion toxins Grant 9,764,006 - Wang , et al. September 19, 2 | 2017-09-19 |
| Recombinant cytotoxic T-lymphocyte-associated protein 4 (CTLA4) Grant 9,758,566 - Wang , et al. September 12, 2 | 2017-09-12 |
| Anti-human Chemokine (C-C motif) Receptor 4 Immunotoxins App 20170121419 - Wang; Zhirui ; et al. | 2017-05-04 |
| Bivalent IL-2 Fusion Toxins App 20160030526 - Wang; Zhirui ; et al. | 2016-02-04 |
| Human Ctla4 Mutants And Use Thereof App 20160017018 - Wang; Zhirui ; et al. | 2016-01-21 |
| Reducing Immunogenicity Of Xenogeneic Transplant Tissues App 20150164634 - Yamada; Kazuhiko ; et al. | 2015-06-18 |
| Recombinant Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA4) App 20150118260 - Wang; Zhirui ; et al. | 2015-04-30 |
| Miniature Swine Transgenic For One Or More Coagulation Factors App 20150106962 - Sachs; David H. ; et al. | 2015-04-16 |
| Multiple Administrations Of Umbilicus Derived Cells App 20090220995 - Sachs; David H. ; et al. | 2009-09-03 |
| Inbred miniature swine and uses thereof App 20070033668 - Sachs; David H. ; et al. | 2007-02-08 |
| Inbred miniature swine and uses thereof Grant 7,141,716 - Sachs , et al. November 28, 2 | 2006-11-28 |
| Allogeneic and xenogeneic transplantation App 20060147428 - Sachs; David H. | 2006-07-06 |
| Allogeneic and xenogeneic transplantation Grant 6,911,220 - Sachs June 28, 2 | 2005-06-28 |
| Inbred miniature swine and uses thereof App 20030115620 - Sachs, David H. ; et al. | 2003-06-19 |
| Alpha (1,3) galactosyl transferase negative swine App 20030014770 - Gustafsson, Kenth T. ; et al. | 2003-01-16 |
| Specific tolerance in transplantation App 20020127713 - Sachs, David H. | 2002-09-12 |
| Tolerance to natural antibody antigens App 20020114787 - Iacomini, John J. ; et al. | 2002-08-22 |
| Specific tolerance in transplantation Grant 6,306,651 - Sachs October 23, 2 | 2001-10-23 |
| Induced tolerance to xenografts Grant 6,296,846 - Sachs , et al. October 2, 2 | 2001-10-02 |
| .alpha.(1,3) galactosyltransferase negative porcine cells Grant 6,153,428 - Gustafsson , et al. November 28, 2 | 2000-11-28 |
| Transplantation and graft-versus-host-disease Grant 5,843,425 - Sachs , et al. December 1, 1 | 1998-12-01 |
| Xenograft thymus Grant 5,658,564 - Sykes , et al. August 19, 1 | 1997-08-19 |
| DNA encoding procine interleukin-10 Grant 5,624,823 - Sachs , et al. April 29, 1 | 1997-04-29 |
| Specific tolerance in transplantation Grant 5,614,187 - Sachs March 25, 1 | 1997-03-25 |
| NCAGE Code | 44TM6 | SACHS DAVID H |
| CAGE Code | 44TM6 | SACHS, DAVID H |
| DUNS | 603845533 | SACHS, DAVID H |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 